Mondelez International (MDLZ)
NASDAQConsumer StaplesFood ConfectionersSnapshot 2026-10-30
$64.94+3.85%
Close 2026-10-30 · 1-day change
NASDAQConsumer StaplesFood ConfectionersSnapshot 2026-10-30
Research Workspace
Put MDLZ beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Packaged Foods & Meats is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Adjusted EPS growth flat to 5% on constant currency basis for 2026: Direct metric needs a verified mapping.
View ThesisRevenue is growing steadily — about 6% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation, earnings delivery, the balance sheet, market reaction to earnings.
View ManagementExpectations look high — the market is pricing in about 26% growth a year, above the roughly 3% analysts expect, leaving little room for error.
View ValuationRelatively steady — typically moves about 1% a day.
View RiskMDLZ’s case rests on durable, volume-led growth, though recent revenue growth is slowing. Revenue growth eased from 8.2% to 4.1% to 2.3%, despite three consecutive earnings beats. Q3 2026 adjusted EPS beat consensus by 8.3%. MDLZ trades at 22× earnings versus 13× for peers and 22× its own history. The market prices in more growth than our forecast, leaving expectations full. The 18% next-quarter miss probability adds risk, and the thesis flags adjusted EPS growth of flat to 5% for 2026, with its metric mapping unverified. Peer multiples imply a price about 22% below where it trades; the thesis is on watch. This read is provisional.
Trailing returns as of 2026-10-30. MDLZ is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 24 analysts currently covering MDLZ (as of Oct 2026).
Based on 8 Wall Street analysts offering 12-month price targets for MDLZ in the last 4 months.
Continue this research
Compare MDLZ with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| MDLZ Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 13 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Packaged Foods & Meats — fair value, gap to price, and forward P/E.
Compare the value case
Put MDLZ next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Reinvest in brands and growth platforms
Majority investment expands the growth portfolio, though the deal’s financial contribution is unspecified.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $64.94
The last 12 months of price, then the range of analyst 12-month targets from today’s $64.94.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Threatens: Deliver volume-led organic revenue growth
Health-conscious shoppers cutting back threatens US chocolate volumes and volume-led growth.
Advances: Deliver volume-led organic revenue growth
Reported 2027 EPS outlook and emerging-market distribution runway support growth, though cocoa surplus tempers the signal.
Advances: Deliver volume-led organic revenue growth
Official earnings-call discussion provides direct evidence on growth, costs, cash flow, and outlook.
Acquisition expands healthier snack options, but no evidence it materially changes growth or financial objectives.
Advances: Adjusted EPS growth of flat to 5%
Earnings beat supports adjusted EPS objective, though headline provides limited detail.
Advances: Deliver volume-led organic revenue growth
Rising profit and sales on emerging-market growth support volume-led growth objectives.
Advances: Deliver adjusted EPS growth of flat to 5%
Profit beat aided by cost cuts supports EPS delivery, though not necessarily durable volume-led growth.
